385 related articles for article (PubMed ID: 30668365)
1. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
[TBL] [Abstract][Full Text] [Related]
2. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
[TBL] [Abstract][Full Text] [Related]
3. Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.
Jiang Y; He Q; Zhang T; Xiang W; Long Z; Wu S
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436944
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
Yang J; Tian S; Zhao J; Zhang W
Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
[TBL] [Abstract][Full Text] [Related]
5. Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases.
Li G; Xu Q; Han K; Yan W; Huang C
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32990315
[TBL] [Abstract][Full Text] [Related]
6. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.
Yu G; Zhang Y; Ren W; Dong L; Li J; Geng Y; Zhang Y; Li D; Xu H; Yang H
Int J Chron Obstruct Pulmon Dis; 2017; 12():85-94. PubMed ID: 28053519
[TBL] [Abstract][Full Text] [Related]
8. [Integrated strategy for biomarkers of stable coronary heart disease with phlegm and blood stasis syndrome based on RNA-seq and network pharmacology].
Yang G; Zhou SY; Wang J; Hu J; Pan JH
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1908-1915. PubMed ID: 37282967
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease.
Wang D; Tian L; Shi C; Wei YX; Wang H; Liu TT; Gong M; Zhang YW; Yu RG; Wu XH
Comput Biol Med; 2020 Jul; 122():103825. PubMed ID: 32658730
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
11. Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy.
Li H; Liu L; Liu C; Zhuang J; Zhou C; Yang J; Gao C; Liu G; Lv Q; Sun C
Med Sci Monit; 2018 Aug; 24():5668-5688. PubMed ID: 30108199
[TBL] [Abstract][Full Text] [Related]
12. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking.
Jin Y; Yin X; Li Z; Xu J
Ann Palliat Med; 2021 Mar; 10(3):3205-3218. PubMed ID: 33849106
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis.
Li C; Zhang WY; Yu Y; Cheng CS; Han JY; Yao XS; Zhou H
Phytomedicine; 2019 Mar; 56():261-268. PubMed ID: 30668346
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation.
Li W; Mao X; Wu H; Guo M; Su X; Lu J; Guo Q; Li T; Wang X; Su W; Zhang Y; Lin N
Phytomedicine; 2020 Feb; 67():153156. PubMed ID: 31901568
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Xiong-Pi-Fang in treating coronary heart disease associated with depression: A systematic pharmacology strategy and in vivo pharmacological validation.
Deng F; Li X; Tang C; Chen J; Fan B; Liang J; Zhen X; Tao R; Zhang S; Cong Z; Du W; Zhao H; Xu L
J Ethnopharmacol; 2022 Nov; 298():115631. PubMed ID: 35987411
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.
Yu G; Wang W; Wang X; Xu M; Zhang L; Ding L; Guo R; Shi Y
BMC Complement Altern Med; 2018 Nov; 18(1):292. PubMed ID: 30382864
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on disease burden and direct medical cost of Xueshuan Xinmaining Tablets in patients with cerebral infarction and coronary heart disease].
Hu J; Gao SQ; Wang J; Li J; Chen HW; Dai ZQ; Liao X
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2309-2316. PubMed ID: 34047135
[TBL] [Abstract][Full Text] [Related]
20. ["Multi-component-multi-target-multi-pathway" mechanism of Kuihua Hugan Tablets based on network pharmacology].
Shen HB; Zhou YN; Zheng J; Zhu RH
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1464-1474. PubMed ID: 31090306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
